Nimer, 2,148 patient vitamin C prophylaxis study: 25% lower hospitalization [p=0.08] and 17% lower severe cases [p=0.18] https://c19p.org/nimerc
copied to clipboard
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization
et al., Bosnian Journal of Basic Medical Sciences, doi:10.17305/bjbms.2021.7009
Retrospective survey based analysis of 2,148 COVID-19 recovered patients in Jordan, showing lower risk of severity and hospitalization with vitamin C prophylaxis, without statistical significance.
|
risk of hospitalization, 24.7% lower, RR 0.75, p = 0.08, treatment 52 of 651 (8.0%), control 167 of 1,497 (11.2%), NNT 32, adjusted per study, odds ratio converted to relative risk, multivariable.
|
|
risk of severe case, 17.0% lower, RR 0.83, p = 0.18, treatment 66 of 651 (10.1%), control 194 of 1,497 (13.0%), NNT 35, adjusted per study, odds ratio converted to relative risk, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Nimer et al., 2/28/2022, retrospective, Jordan, Middle East, peer-reviewed, survey, 4 authors, study period March 2021 - July 2021.
Contact:
rmnimer@just.edu.jo.
nimer
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.